Application of Transesophageal Echocardiography in Amplatzer Atrial Septal Defect Occluder for Percutaneous Closure of Large Patent Foramen Ovale

<div>Two patients with a large residual RLS underwent TEE and c-TEE at 12 months after the procedure. (a) An oversized PFO occluder device. (b) An intradisc residual shunt. (c) A large residual RLS from the middle of the PFO occluder device. (d) An oversized ASD occluder device and an intradisc residual shunt. c-TEE: contrast transesophageal echocardiography; PFO: patent foramen ovale; RLS: right-to-left shunt; TEE, transesophageal echocardiography.</div>

Cardiovascular Therapeutics

fig4

Figure 4

Figure 4: Application of Transesophageal Echocardiography in Amplatzer Atrial Septal Defect Occluder for Percutaneous Closure of Large Patent Foramen Ovale 

Figure 4 | Application of Transesophageal Echocardiography in Amplatzer Atrial Septal Defect Occluder for Percutaneous Closure of Large Patent Foramen Ovale 